Xinli Han

No.399 WanYuan Road
Minhang, 201102, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Urinary ANGPTL3: a novel noninvasive biomarker for podocyte injury in pediatric glomerular diseases.

Urinary ANGPTL3: a novel noninvasive biomarker for podocyte injury in pediatric glomerular diseases.

Journal: Journal of translational medicine
Published: December 30, 2025

Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria.

Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria.

Journal: Renal failure
Published: November 14, 2024

Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children.

Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children.

Journal: Kidney international reports
Published: September 30, 2024

Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation.

Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation.

Journal: Pediatric nephrology (Berlin, Germany)
Published: March 05, 2024

Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children.

Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children.

Journal: Frontiers in pediatrics
Published: December 01, 2022

Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.

Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.

Journal: International immunopharmacology
Published: October 04, 2022

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.

Journal: Cell death & disease
Published: May 03, 2022

Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.

Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.

Journal: International immunopharmacology
Published: November 18, 2021

PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathway.

PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathway.

Journal: Experimental cell research
Published: February 17, 2021

Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.

Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.

Journal: Biochemical and biophysical research communications
Published: June 07, 2019

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.

Journal: BMC nephrology
Published: February 04, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026